Clinical Trials for Treatment: Basic Science

17 Open Trials. Phone:(877.827.8839)
Protocol No. Title Status
GOG-0237 Comparative Analysis of CA-IX, p16, Proliferative Markers and Human Papilloma Virus (HPV) in the Diagnosis of Significant Cervical Lesions in Patients with a Cytologic Diagnosis of Atypical Glandular Cells (AGC) Open
UCI-03-03 Immunologic Factors Affecting Outcomes in Patients with Liver Cancer Open
UCI-09-17 Biology of Human Melanocytes and Keratinocytes Open
UCI-11-19 Evaluation of Peritumoral Renal Adipose Tissue to Renal Cancer Aggressiveness Open
UCI-12-18 (BIOREPOSITORY PROTOCOL) Comprehensive, Coordinated Clinical, Imaging and Histological Database for the Study of Neurological Outcomes of Cancer and Cancer Treatments Open
UCI-13-02 Assessing Fitness, Physical Activity and Leukocyte Genomic Response to Exercise in Acute Lymphoblastic Leukemia (ALL) Patients in Remission Open
UCI-14-03 Role of Inflammation in the Pathogenesis of Myeloproliferative Neoplasm Open
UCI-15-40 [EXEMPT - REGISTRY TRIAL] Prospective and Retrospective Study of Outcomes for Patients with Malignant Melanoma Open
UCI-16-31 [EXEMPT - RETROSPECTIVE] Importin α is a Novel Biomarker of Barrett's Esophagus (BE)-Related Dysplasia & Cancer and Promotes Growth of BE-Derived Cancer Cells by Inducing Aberrant VEGF Expression Open
UCI-16-70 Evaluation of Mitochondrial Priming in T Cell Lymphomas Open
UCI-16-88 Development of Esophageal and Gastric Cancer Patient Derived Xenograft Mouse Models to Investigate Chemotherapy Resistance and Tumor Cell Response Open
UCI-17-05 Understanding Intratumoral Heterogeneity Using Single Cell RNA Sequencing Open
UCI-17-08 Peripheral Hormonal Profile in Women with Breast Lesions Open
UCI-17-43 Blood Collection Protocol for Circulating Tumor Cells, Circulating Cancer Associated Fibroblasts and Tissue Factor in Breast Cancer Patients Open
UCI-17-72 Evaluating the microbiome in myeloproliferative neoplasm Open
UCI-17-73 A Sequential 2-arm, Open-label Phase I Study to Evaluate the Effects of Encorafenib in Combination with Binimetinib on the Pharmacokinetics of Losartan, Midazolam, Caffeine, Omeprazole, and Dextromethorphan Administered in a Cocktail Approach and on the Pharmacokinetics of Rosuvastatin in Patients with BRAF V600-mutant Unresectable or Metastatic Melanoma or Other Advanced Solid Tumors Open
UCI-17-76 Variations in Local Microbiome Populations in Normal Colorectal Tissue and Polyps Open